"Current Pharmacogenomics and Personalized Medicine provides access to the most recent progress and opinion in this rapidly developing field and is an indispensable source of information for scientists and clinicians who want to keep in touch with the expanding interdisciplinary advancements."
Brian Tomlinson Professor of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR.
"Current Pharmacogenomics and Personalized Medicine provides interdisciplinary and integrative perspectives on most recent advances in personalized medicine. The scope of diseases and pharmaceutical outcomes covered is broad and timely. I believe the journal is an essential reading for anyone who aims to quickly grasp the cutting edge in pharmacogenomics and predictive medicine."
Sunao Kaneko President, Japanese Society of Clinical Neuropsychopharmacology
"Expert Reviews in Current Pharmacogenomics and Personalized Medicine present complicated disease processes and their treatment options in a succinct manner. They are an invaluable resource for both clinicians and biomedical scientists."
Judy Wong Canada Research Chair in Genome Maintenance, University of British Columbia, Vancouver, Canada
"Current Pharmacogenomics and Personalized Medicine integrates the advances across therapeutic areas as well as molecular, clinical and social sciences. I believe the journal will contribute to the new interdisciplinary field of personalized medicine to gain its identity and accelerate its evolution."
S. Oguz Kayaalp Professor of Pharmacology and Honorary Member, The Turkish Academy of Sciences, Ankara, Turkey
Ramón Cacabelos Institute of Medical Science and Genomic Medicine Corunna Spain
Dr. Ramón Cacabelos is Professor of Genomic Medicine and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Ph.D. from Santiago University, and D.M.Sci. (Psychiatry) from Osaka University Medical School, Osaka, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics and pharmacogenomics of neurodegenerative disorders. He has published over 600 papers and 24 books, is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics, and is President of the World Association of Genomic Medicine.